Literature DB >> 14995982

Compliance with recommended prophylaxis for venous thromboembolism: improving the use and rate of uptake of clinical practice guidelines.

A K Kakkar1, B L Davidson, S K Haas.   

Abstract

Although several authoritative, evidence-based, guidelines for the prevention of venous thromboembolism (VTE) have been published, the use of VTE prophylaxis in routine clinical practice varies markedly. Even in orthopedic surgery, the indication for which prophylaxis is used most often, a significant proportion of surgeons do not use routine prophylaxis. When prophylaxis is used, guideline recommendations are often not followed. A number of factors may contribute to the under-use of guidelines. Physician-related factors include: a lack of awareness of, or familiarity with, the guidelines; a perception that VTE is not a significant problem or that VTE prophylaxis is ineffective; and concern about potential bleeding risks. The guidelines may also be perceived to be too complicated or difficult to apply in a routine manner. In addition, a lack of facilities or resources may also present a barrier to implementation of the guidelines. A number of strategies are being investigated in an attempt to improve compliance with guidelines for VTE prophylaxis. For example, the Investigators Against Thromboembolism (INATE) initiative has developed a simplified pocket guideline on VTE prophylaxis in orthopedic and trauma surgery in order to raise awareness of the current guideline recommendations.

Entities:  

Mesh:

Year:  2004        PMID: 14995982     DOI: 10.1111/j.1538-7933.2004.00588.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  20 in total

Review 1.  Reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in inpatients having surgery: summary of NICE guidance.

Authors:  Jennifer Hill; Tom Treasure
Journal:  BMJ       Date:  2007-05-19

2.  Venous thromboembolism in COPD hospitalized patients.

Authors:  Raquel Barba; Antonio Zapatero; Javier Marco; Juan E Losa; Susana Plaza; Jose Manuel Casas; Jesús Canora
Journal:  J Thromb Thrombolysis       Date:  2012-01       Impact factor: 2.300

Review 3.  Benefits of novel oral anticoagulant agents for thromboprophylaxis after total hip or knee arthroplasty.

Authors:  Richard J Friedman
Journal:  Am Health Drug Benefits       Date:  2012-03

4.  Community engagement strategies in the original and renewal applications for CTSA grant funding.

Authors:  Jessica Holzer; Nancy Kass
Journal:  Clin Transl Sci       Date:  2013-11-06       Impact factor: 4.689

5.  Improving access to cancer guidelines: feedback from health care professionals.

Authors:  I S Sahota; X Kostaras; N A Hagen
Journal:  Curr Oncol       Date:  2015-12       Impact factor: 3.677

Review 6.  [Prevention of perioperative venous thromboembolism in children].

Authors:  Werner Streif
Journal:  Wien Med Wochenschr       Date:  2009-10

7.  Development of national performance measures on the prevention and treatment of venous thromboembolism.

Authors:  Dale W Bratzler
Journal:  J Thromb Thrombolysis       Date:  2010-02       Impact factor: 2.300

8.  Assessment of risk and prophylaxis for deep vein thrombosis and pulmonary embolism in medically ill patients during their early days of hospital stay at a tertiary care center in a developing country.

Authors:  Ambarish Pandey; Nivedita Patni; Mansher Singh; Randeep Guleria
Journal:  Vasc Health Risk Manag       Date:  2009-08-06

9.  Designing and implementing effective venous thromboembolism prevention protocols: lessons from collaborative efforts.

Authors:  Greg Maynard; Jason Stein
Journal:  J Thromb Thrombolysis       Date:  2010-02       Impact factor: 2.300

10.  Prevention and treatment of venous thromboembolism in the elderly patient.

Authors:  Enrico Tincani; Mark A Crowther; Fabrizio Turrini; Domenico Prisco
Journal:  Clin Interv Aging       Date:  2007       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.